Current Alzheimer Research
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 7
Author(s): Andrew J. Saykin*
Affiliation:
- Indiana University School of Medicine Indianapolis, IN,United States
Export Options
About this article
Cite this article as:
Saykin J. Andrew*, Meet Our Editorial Board Member, Current Alzheimer Research 2017; 14 (7) . https://dx.doi.org/10.2174/156720501407170619154022
DOI https://dx.doi.org/10.2174/156720501407170619154022 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hydrogen Sulfide: From Physiology to Pharmacology
Inflammation & Allergy - Drug Targets (Discontinued) Hypertension in Pregnancy: A Review of Current Guidelines
Current Women`s Health Reviews Pharmacological Support of Neurorehabilitation
Current Drug Therapy A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9
Current Drug Targets Bioorganic Compounds Produced by the Fungus Monascus and their Use in Health Sciences and Medicine
Mini-Reviews in Organic Chemistry Teratological Consequences of Nitric Oxide Synthesis Inhibition
Current Pharmaceutical Design Dorsal Stream Dysfunction in Children. A Review and an Approach to Diagnosis and Management
Current Pediatric Reviews Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review
Current Drug Therapy Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy
CNS & Neurological Disorders - Drug Targets The Role of Inflammation in Neurological Disorders
Current Pharmaceutical Design Current Issues in Intravenous Fluid Use in Hospitalized Children
Reviews on Recent Clinical Trials Edaravone (3-Methyl-1-Phenyl-2-Pyrazolin-5-one), A Novel Free Radical Scavenger, for Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Current Cancer Drug Targets Microbubbles as Drug Delivery Systems in Cerebrovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Methodological Considerations to Understand the Sensory Function of TRP Channels
Current Pharmaceutical Biotechnology Therapeutic Medical Hypothermia-A Multispecialty Approach
Recent Patents on Cardiovascular Drug Discovery All Cognitive Systems but Speed and Visuospatial Functions Reduce the Effect of CSF Pathology on Other Systems
Current Alzheimer Research Postoperative Delirium
Current Drug Targets Conference Report (The XVth International Symposium of Brain Edema and Cellular Injury)
CNS & Neurological Disorders - Drug Targets